The Children’s Place, Inc. Issues Chairman’s Letter to Shareholders
May 24, 2024 08:16 ET
|
The Children's Place, Inc.
SECAUCUS, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands with an industry-leading digital-first model,...
Rail Vision Reflects on Positive Operational Highlights Since the Start of 2024: Scaling Up Commercialization
May 24, 2024 08:15 ET
|
Rail Vision Ltd.
Announced first-ever commercial installation of its AI-driven systems in a national railways lineAchieved regulatory approval and certificate for railway operation in EuropeJoined NVIDIA metropolis to...
BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility
May 24, 2024 08:00 ET
|
BranchOut Food Inc.
BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
May 24, 2024 08:00 ET
|
Genelux Corporation
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
May 24, 2024 08:00 ET
|
BriaCell Therapeutics Corp.
83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression free survival (PFS) of 4.1 months in ADC...
Monopar Announces CFO Succession
May 24, 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer...
Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit
May 24, 2024 08:00 ET
|
Cullinan Therapeutics, Inc.
CAMBRIDGE, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced...
Alkami to Present at William Blair 44th Annual Growth Stock Conference
May 24, 2024 08:00 ET
|
Alkami Technology, Inc.
PLANO, Texas, May 24, 2024 (GLOBE NEWSWIRE) -- Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions provider for financial institutions in the U.S.,...
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
May 24, 2024 08:00 ET
|
IN8bio, Inc
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Meeting
May 24, 2024 08:00 ET
|
CG Oncology Inc.
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab